KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Non-Current Debt: 2017-2019

Historic Non-Current Debt for Xenon Pharmaceuticals (XENE) over the last 2 years, with Dec 2019 value amounting to $10.9 million.

  • Xenon Pharmaceuticals' Non-Current Debt was N/A to $10.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $10.9 million, marking a year-over-year change of. This contributed to the annual value of $10.9 million for FY2019, which is N/A change from last year.
  • Xenon Pharmaceuticals' Non-Current Debt amounted to $10.9 million in FY2019, which was up 78.39% from $6.1 million recorded in FY2017.
  • In the past 5 years, Xenon Pharmaceuticals' Non-Current Debt ranged from a high of $10.9 million in FY2019 and a low of $6.1 million during FY2017.
  • In the last 2 years, Xenon Pharmaceuticals' Non-Current Debt had a median value of $8.5 million in 2017 and averaged $8.5 million.